Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer announce positive results for Humira biosimilar

January 6, 2017
Medical Communications, Research and Development, Sales and Marketing Humira, Pfizer, biosimilar

Pfizer has released the successful Phase 3 results to its biosimilar to AbbVie’s blockbuster Humira, meeting its primary endpoint in …

News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

January 6, 2017
Medical Communications biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

The start of 2017 has already had some big stories hit the news, with many companies taking the opportunity to …

News
novartis_window

Novartis and Ionis enter $1bn cardiovascular drug deal

January 6, 2017
Medical Communications, Research and Development, Sales and Marketing Akcea, Akcea Therapeutics, Ionis, Ionis Pharmaceuticals, cardiovascular

Ionis Pharmaceuticals and one of its wholly-owned subsidiaries Akcea Therapeutics have entered into a partnership with Novartis worth potentially more …

News
peter_schurrenberger

Insider interview: Roche discusses the importance of sustainability in pharma manufacturing

January 6, 2017
Manufacturing and Production, Medical Communications Roche

Peter Schurrenberger, Chief Safety, Health and Environment Officer at Roche, discusses their recent recognition as a leader for corporate action …

News
cancer_cells

New research reveals how cancer cells grow and spread through body

January 6, 2017
Medical Communications Cancer, Cancer Research UK, ICR, Institute of Cancer Research, cancer research, cell movement

Research conducted by The Institute of Cancer Research (ICR), co-funded by Cancer Research UK, has discovered how cancer cells are …

News
astrazeneca_sign_sky

AstraZeneca acquires biotech’s unique antithrombotic drug

January 5, 2017
Medical Communications, Sales and Marketing APT, AstraZeneca, acquisition

AstraZeneca has announced that it has entered into a research collaboration, option and asset purchase agreement with APT Therapeutics, a …

News
wockhardt_hospital_mumbai

Wockhardt’s Gujarat plant hit with FDA warning letter

January 5, 2017
Manufacturing and Production FDA, Wockhardt

Indian pharma and biotech firm Wockhardt has been accused of violating current good manufacturing practice (CGMP) regulations in a letter …

News
pregnancy

Morning sickness pill scientific backing called into question

January 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diclectin, Diclegis, Duchesnay, FDA, kim kardashian, morning sickness

Many women suffer from morning sickness during the early stages of pregnancy and some suffer from hyperemesis gravidarum, acute morning …

News
dengue_mosquito_web

Philippine FDA orders Sanofi to pull dengue vaccine ads

January 5, 2017
Medical Communications, Sales and Marketing Philippines, Sanofi, Vaccine, dengue, virus

Sanofi has suffered a major blow to its dengue immunisation programme in the Philippines after it was requested the company …

News
sheep

FDA steps up fight against superbugs with livestock ruling

January 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, FDA, Guidelines, Livestock, agriculture, antibiotic resistance, farmers

The FDA began the year by announcing the implementation of ‘Guidance for Industry #213’. The new rule is a voluntary …

News
alessandro-riva

Gilead makes move in oncology by snaffling Riva from Novartis

January 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Novartis, oncology

Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …

Appointment
inotek_logo

Inotek’s glaucoma lead candidate falls at Phase 3 trial

January 4, 2017
Research and Development Glaucoma, inotek, inotek pharma

Inotek Pharmaceutical announced that its lead candidate, trabodenoson, a drug designed to treat glaucoma, had failed to outperform placebos in …

News
sun_pharma

Blast at Sun Pharma factory kills two

January 4, 2017
Medical Communications, Research and Development Sun Pharma, factory, fire

A blast at Sun Pharma’s Ahmednagar factory caused the deaths of two workers and injured a further two. The four …

News
amgen_hq

Amgen’s patent win upheld against Sanofi-Regeneron

January 4, 2017
Medical Communications, Research and Development Amgen, Regeneron, Sanofi, patent

In March 2016, Amgen won two major patent cases against Sanofi and Regeneron over their drug, Praleunt, after it was …

News
texas-star

Texas launches lawsuit against FDA over lethal drug shipment

January 4, 2017
Medical Communications, Research and Development FDA, texas

The state of Texas has filed a lawsuit against the FDA to try to force a decision to be made …

News
novartis_window

Greek authorities raid Novartis’ offices after bribery allegations

January 4, 2017
Medical Communications, Research and Development Greece, Greek, Novartis, bribery

The investigation into practices by Novartis in its Greek operations has been accelerated after the attempted suicide of a Greek …

News
syringe

Sanofi and MSD end their joint vaccines partnership

January 3, 2017
Research and Development MSD, Sanofi, Sanofi pasteur msd

With a new year comes a fresh start, and so it was the case with Sanofi and MSD’s joint vaccine …

News
giovanni_caforio

Giovanni Caforio to be made chairman of the board at BMS

January 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Giovanni Caforio, bristol myers-squibb

Bristol-Myers Squibb has announced that Giovanni Caforio has been appointed chairman of the board. Caforio will take up the position …

Appointment

Biogen’s gains late-year drug approval first for controversially expensive drug

January 3, 2017
Manufacturing and Production, Sales and Marketing Biogen, FDA

The FDA squeezed in one last approval before the year ended with the first approval for a drug to treat …

News
seattle_genetics

Four die in Seattle Genetics’ drug trial

January 3, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Seattle Genetics, patient deaths, trial hold

Seattle Genetics released that the FDA had placed a hold had been placed on clinical trials involving its experimental cancer …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026